ITEM 8.01-OTHER EVENTS

On June 12, 2020, BOV Solutions ("Bov"), a division of the Starco Group that contract manufactures products for Starco Brands, Inc. ("Starco Brands") received a final report (the "Report") from Microbac Laboratories, Inc. ("Microbac") with the results of a virucidal efficacy suspension test for severe acute respiratory syndrome-related Coronavirus 2 (SARS-CoV-2)(COVID-19 Virus) (the "Test") for Starco Brands' owned products, the Breathe® Hand Spray Sanitizer Spray and Gel hand sanitizer. The Breathe Hand Spray Sanitizer Spray and Gelwere evaluated for the ability to inactivate Sever Acute Respiratory Syndrome-related Coronavirus 2 (SARS-CoV-2)(COVID-19 Virus). Microbac personnel performed the inactivation procedure using Severe Acute Respiratory Syndrome-related Corononavirus 2 (SARS-CoV-2)(COVID-19 Virus) to spike the test article solution. Samples were titrated by 50% tissue culture infectious dose endpoint assay using Vero-E6 cells. When tested as described, the Breathe Hand Sanitizer Spray and Gelshowed a ?3.84 Log10 reduction against Severe Acute Respiratory Syndrome-related Coronavirus 2 (SARS-CoV-2)(COVID-19 Virus) when the target virus was exposed to the Breath Hand Sanitizer Spray and Gel for 15 and 30 seconds at 21 degrees C.

© Edgar Online, source Glimpses